Cargando…

Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

Detalles Bibliográficos
Autores principales: Toll, Stephanie A., Tran, Hung N., Cotter, Jennifer, Judkins, Alexander R., Tamrazi, Benita, Biegel, Jaclyn A., Dhall, Girish, Robison, Nathan J., Waters, Kaaren, Patel, Palak, Cooper, Robert, Margol, Ashley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197959/
https://www.ncbi.nlm.nih.gov/pubmed/37204254
http://dx.doi.org/10.18632/oncotarget.28445
_version_ 1785044649946120192
author Toll, Stephanie A.
Tran, Hung N.
Cotter, Jennifer
Judkins, Alexander R.
Tamrazi, Benita
Biegel, Jaclyn A.
Dhall, Girish
Robison, Nathan J.
Waters, Kaaren
Patel, Palak
Cooper, Robert
Margol, Ashley S.
author_facet Toll, Stephanie A.
Tran, Hung N.
Cotter, Jennifer
Judkins, Alexander R.
Tamrazi, Benita
Biegel, Jaclyn A.
Dhall, Girish
Robison, Nathan J.
Waters, Kaaren
Patel, Palak
Cooper, Robert
Margol, Ashley S.
author_sort Toll, Stephanie A.
collection PubMed
description
format Online
Article
Text
id pubmed-10197959
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-101979592023-05-20 Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Toll, Stephanie A. Tran, Hung N. Cotter, Jennifer Judkins, Alexander R. Tamrazi, Benita Biegel, Jaclyn A. Dhall, Girish Robison, Nathan J. Waters, Kaaren Patel, Palak Cooper, Robert Margol, Ashley S. Oncotarget Addendum Impact Journals LLC 2023-05-19 /pmc/articles/PMC10197959/ /pubmed/37204254 http://dx.doi.org/10.18632/oncotarget.28445 Text en Copyright: © 2023 Toll et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Addendum
Toll, Stephanie A.
Tran, Hung N.
Cotter, Jennifer
Judkins, Alexander R.
Tamrazi, Benita
Biegel, Jaclyn A.
Dhall, Girish
Robison, Nathan J.
Waters, Kaaren
Patel, Palak
Cooper, Robert
Margol, Ashley S.
Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
title Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
title_full Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
title_fullStr Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
title_full_unstemmed Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
title_short Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
title_sort addendum: sustained response of three pediatric braf(v600e) mutated high-grade gliomas to combined braf and mek inhibitor therapy
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197959/
https://www.ncbi.nlm.nih.gov/pubmed/37204254
http://dx.doi.org/10.18632/oncotarget.28445
work_keys_str_mv AT tollstephaniea addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT tranhungn addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT cotterjennifer addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT judkinsalexanderr addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT tamrazibenita addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT biegeljaclyna addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT dhallgirish addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT robisonnathanj addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT waterskaaren addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT patelpalak addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT cooperrobert addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy
AT margolashleys addendumsustainedresponseofthreepediatricbrafv600emutatedhighgradegliomastocombinedbrafandmekinhibitortherapy